A new spin-off of Amsterdam UMC, location AMC, HaemoPulse, started in the first months of 2019. HaemoPulse will develop non-invasive optical technology for continuous real-time monitoring of blood hematocrit.
Being able to measure hematocrit in such a manner opens a wide range of clinical applications, such as tracking of fluid balance in critically ill patients in the ICU, or monitoring of fluid retention of dialysis patients between dialysis treatments. Current clinical techniques for such measurements are insufficiently accurate or require expensive, time-consuming, lab testing of invasively acquired blood samples.
HaemoPulse intends to provide the technology that provides doctors with critical information on fluid balance and blood hematocrit that they currently lack. The scientific founder, Dr. Alan Riordan, is an AMC researcher and the company is developing the technology with the biomedical optics research group of Prof. Ton van Leeuwen at AMC.
“With this agreement, we fortify our collaboration, reaffirming our dedication to diversity, sustainability, and entrepreneurship – values exemplified by DNNL. An endeavor that aligns with the educational and research efforts we stand for as a university,” says VU President Jonkman.
NewsKepler Vision Technologies, a spin-off company from the University of Amsterdam, secured a significant €1.5M investment from ROM InWest last month. The Dutch company will use the funds to accelerate the production of its ‘Kepler Night Nurse’ solution, a smart technology for care home fall detection. The company is now positioned for global expansion, targeting the UK and US markets.
NewsUvA Ventures Holding has launched the Social Sciences & Humanities (SSH) Impact Fund that aims to capitalize on SSH research by supporting the development of academic spin-offs that address societal challenges. The initiative is a response to the need for practical applications of SSH research, identified through discussions with university researchers. For whom? The SSH […]
News